Репозиторий OAI—PMH
Репозиторий Российская Офтальмология Онлайн по протоколу OAI-PMH
Конференции
Офтальмологические конференции и симпозиумы
Видео
Видео докладов
Источник
Разработка метода терапии рецидивирующих эпителиальных дефектов роговицы на основе «протектора эпителия роговицы гелевого»Библиография
Библиография
1. Азнабаев М.Т., Даутова З.А., Суркова В.К. Новый препарат ранозаживляющего действия // Боевые повреждения органа зрения.– 2003. - С. 47.
2. Бржеский В.В., Егорова Г.Б., Егоров Е.А. Синдром «сухого глаза» и заболевания глазной поверхности: клиника, диагностика, лечение // Бржеский В.В., Егорова Г.Б., Егоров Е.А. - М.: ГЭОТАР-медиа, 2016. – 448 с.
3. Бржеский В.В., Сомов Е.Е. Клиническая диагностика и лечение больных с сухим кератоконъюнктивитом на почве синдрома Cъегрена // Офтальмохирургия и терапия. - 2001. - № 1. - С.42-46.
4. Горбунова К.С. Регулирование фибропластических процессов в склеральной ране при помощи сульфатированных гликозаминогликанов: Дис. … канд. мед. наук. - М., 2013. - 121 с.
5. Егорова Г.Б., Фёдоров А.А., Митичкина Т.С., Шамсудинова А.Р., Сафонова Т.Р. Влияние слёзозаместительной и корнеопротекторной терапии на состояние глазной поверхности при синдроме «сухого глаза» // РМЖ. Клин. Офтальмол. – 2015. - №1. – С. 4.
6. Канюков В.Н., Стадников А.А., Трубина О.М., Яхина О.М. Аппликация биопластического материала«Гиаматрикс» при заболеваниях роговицы// Вестник ОГУ. - 2013. - №4. - С. 243-235.
7. Каспарова Е.А., Каспаров А.А., Марченко Н.Р. Рецидивирующая эрозия роговицы: диагностика и лечение // Вестник офтальмологии. – 2010. – №126(5). – С.3-8.
8. Кучеренко А.М., Пампуха В.М., Дрожина Г.И., Лившиц Л.А. Роль полиморфизма генов ИЛ1бета, ИЛ6 и ИЛ8 в развитии рецидивирующей эрозии роговицы у пациентов с наследственными стромальными дистрофиями роговицы // Цитол. Генет. – 2013. - №47(3). – С.42-45.
9. Литвак Г.Ю., Баринов А.В., Комаров В.В., Тюнина Г.К. с соавт. Трансплантация первичной культуры островковой ткани ксеногенной поджелудочной железы больным сахарным диабетом // Технологии живых систем. - 2010. - Т. 7. - No 1. - С. 19-27.
10. Майчук Д.Ю. Рецидивирующие эрозии роговицы: особенности возникновения и лечения// Новое в офтальмологии. – 2014. - №3. – С. 72-75
11. Майчук Д.Ю. Эрозии роговицы: клинические формы, новые методы лечения // РМЖ«Клиническая офтальмология». – 2004. – No1. – C.17.
12. Панасюк А.Ф., Ларионов Е.В. Хондроитинсульфаты и их роль в обмене хондроцитов и межклеточного матрикса хрящевой ткани // Науч.-практ. ревматология. - 2010. - №3. - С. 104-108
13. Перова Н.В., Порунова Ю.В., Урьяш В.Ф., Фаминская Л.А. с соавт. Биодеградируемый коллагенсодержащий матрикс СферогельТМ для клеточной трансплантации// Перспективные материалы. – 2004. – No 2. – С. 52-59.
14. Покровский В.И., Брико Н.И. Общая эпидемиология с основами доказательной медицины. Руководство к практическим занятиям // Покровский В.И., Брико Н.И., Бражников А.Ю., Кирьянова Е.В. с соавт. - М.: ГЭОТАР-медиа, 2010. – 400с.
15. Сайковский Р.С., Савенкова Н.А., Аверьянов А.В., Лисица А.В. Эффективность применения препарата Сферогель для лечения гонартроза // Клиническая практика. - 2013. - №3. - С. 4-10.
16. Севастьянов В.И., Перова Н.В. Биополимерный гетерогенный гидрогель СфероГель – инъекционный биодеградируемый имплантат для заместительной и регенеративной медицины// Практическая медицина. – 2014. -№8(84). – С. 110-116.
17. Севастьянов В.И., Перова Н.В., Немец Е.А. с соавт. Биополимерные матриксы в тканевой инженерии // Сборник тезисов V Всероссийского симпозиума с международным участием «Актуальные вопросы тканевой и клеточной трансплантологии, Изд-во«Башкортостан», Уфа. - 2012. – С.198 - 199.
18. Севастьянов В.И., Перова Н.В., Сайковский Р.С., Соловьева И.В. Применение инъекционных форм биополимерных гетерогенных гидрогелей при дегенеративно-дистрофических поражениях суставов. Практическое пособие для врачей. - Москва: Триада, 2012. – С. 27.
19. Сулеева Б.О. Дикамбаева М.К., Асанова А.А. с соавт. Способ лечения эпителиальных дефектов роговицы // Вестник КРСУ - 2008. – том 8. - №4. – С.124-126.
20. Тонаева Х.Д. Лимбальная сотрансплантация в профилактике отторжения донорских роговиц при кератопластике высокого риска: Дисс. … канд. мед. наук. – М., 2014.
21. Труфанов С.В., Маложен С.А., Полунина Е.Г., Пивин Е.А., Текеева Л.Ю. Синдром рецидивирующей эрозии роговицы (обзор) // Офтальмология. – 2015. – Т. 12. - №2. – С. 4-12.
22. Федяков А.Г., Древаль О.Н., Кузнецов А.В., Севастьянов Ф.И. с соавт. Экспериментальное обоснование применения гелевого имплантата «Сферо®Гель» и пленочного имплантата «ЭластоПОБ®» при травме периферической нервной системы в эксперименте// Вестник трансплантологии и искусственных органов. - 2009. - Т. XI. - No 4. - С. 75-80.
23. Шумаков В.И., Севастьянов В.И. Биополимерные матриксы для искусственных органов и тканей// Здравоохранение и медицинская техника. - №4. – 2003. - C. 30-33.
24. Яхина О.М. Влияние наноструктурированного биополимера гиалуроновой кислоты на течение репаративного процесса роговицы: Дис. … канд. мед. наук. - М., 2013. – С. 131.
25. Agorogiannis G., Alexaki V., Castana O. et al. Topical application of autologous adipose-derived mesenchymal stem cells (MSCs) for persistent sterile corneal epithelial defect // Graefes. Arch. Clin. Exp. Ophthalmol. – 2012. – Vol. 250. – P. 455-7.
26. Albietz J., Sanfilippo P., Troutbeck R. et al. Management of filamentary keratitis associated with aqueous-deficient dry eye // Optom. Vis. Sci. – 2003. – Vol. 80. – P. 420–30.
27. Albietz J., Bruce A. The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments // J. Curr. Eye Res. – 2001. – Vol. 22. – P. 8–18.
28. Alio J., Rodriguez A., Wrobel Dudzinska D. Eye platelet-rich plasma in the treatment of ocular surface disorders // Curr. Opin. Ophthalmol. – 2015. – Vol. 26. – P. 325-32.
29. Andrasko G., Ryen K. Corneal staining and comfort observed with traditional and silicone hydrogel lenses and multipurpose solution combinations // Optometry. – 2008. – Vol. 79. – P. 444–454.
30. Arlt von F. Über die Verletzungen des Auges in Gerichtsarztlicher Beziehung // Wien Medizin Wochenschr. – 1874. – Vol. 23. – P. 447-449.
31. Avisar R., Robinson A., Appel I. et al. Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis. // Cornea. – 2000. – Vol. 19. – P. 145-7.
32. Barr J., Schechtman K., et al. Corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: baseline prevalence and repeatability of detection // Cornea. – 1999. – Vol. 18(1). – P. 34-46.
33. Beetham W. Filamentary Keratitis // Trans. Am. Ophthalmol. Soc. – 1935. – Vol. 33. – P. 413-35.
34. Begley C., Barr J., Edrington T. et al. Characteristics of corneal staining in hydrogel lens wear // Optom. Vis. Sci. – 1996. – Vol. 73. – P. 193-200.
35. Berman M. The pathogenesis of corneal epithelial defects // Acta Ophthalmol. – 1989. – Vol. 67. – P. 55–64.
36. Bieti G. Cheratite bollosa come rara complicanza post-operatoria dopo estrazione di catarratta // Boll. d'Ocul. – 1937. – Vol. 16. – P. 793-807.
37. Bloomfield S., Gasset A., Forstot S. et al. Treatment of filamentary keratitis with the soft contact lens // Am. J. Ophthalmol. – 1973. – Vol. 76. – P. 978-80.
38. Botella A., Marques J., Marques K. et al. Effectiveness of 100% autologous serum drops in ocular surface disorders // Farmacia Hospitalaria. - 2011. -Vol. 35. – P. 8–13.
39. Boudreau N., Sympson C., Werb Z. et al. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix // Science. - 1995. – Vol. 267. – P. 891–3.
40. Boudreau N., Werb Z., Bissell M. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle // Proc. Natl. Acad. Sci. USA. – 1996. – Vol. 93. – P. 3500–13.
41. Brijacak N., Dekaris I., Gagro A. et al. Therapeutic effect of amniotic membrane in persistent epithelial defects and corneal ulcers in herpetic keratitis // Coll. Antropol. – 2008. – Vol. 32. – P. 21-5.
42. Brodrick J., Dark A., Peace W. Fingerprint dystrophy of the cornea. A histologic study // Arch. Ophthal. – 1974. – Vol. 92. – P. 483-489.
43. Bron A. Diagnosis of dry eye // Survey of ophthalmology. – 2001. - Vol. 45. – P. 221-226.
44. Bron A., Brown N. Some superficial corneal disorders // Trans. Ophthalmol. Soc. UK. – 1971. – Vol. 91. – P. 13.
45. Bron A., Burgess S. Inherited recurrent corneal erosion // Trans. Ophthalmol. Soc. UK. – 1981. – Vol. 101. – P. 239-43.
46. Bron A., Evans V., Smith J. Grading of corneal and conjunctival staining in the context of other dry eye tests // Cornea. - 2003. – Vol. 22(7). – P. 640-50.
47. Bron A., Tripathi R. Cogan’s epithelial microcystic dystrophy: a clinicopathological study // Exp. Eye Res. – 1973. – Vol. 17(4). – P. 398.
48. Bronner A. On some cases of traumatic keratalgia // Trans. Ophthalmol. Soc. UK. – 1889. – Vol. 9. – P. 89-94.
49. Brown N., Bron A. Recurrent erosion of the cornea // Br. J. Ophthalmol. – 1976. – Vol. 60. – P. 84-96.
50. Brown S., Lamberts D., Reid T. et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor I // Arch. Ophthalmol. – 1997. – Vol. 115. – P. 926–7.
51. BrÜckner A. Kurze Mitteilungen. II Rezidivierende Erosion. – Ophthalmologica, Basel. – 1950. – P. 38-43.
52. Carnt N., Jalbert I., Stretton S. et al. Solution toxicity in soft contact lens daily wear is associated with corneal inflammation // Optometry and Vision Sci. – 2007. – Vol. 84. – P. 309-315.
53. Chan E. et al. A randomized controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome // Br. J. Ophthalmol. – 2014. – Vol. 98. – P. 166-71.
54. Chandler P. Recurrent erosion of the cornea // Am. J. Ophthalmol. – 1945. – Vol. 28. – P. 355-363.
55. Chandler P. Recurrent erosion of the cornea // Trans. Am. Ophthalmol. Soc. – 1944. – Vol. 42. – P. 355-7.
56. Chen H., Pires T., Tseng S. Amniotic membrane transplantation for severe neurotrophic corneal ulcers // Br. J. Ophthalmol. – 2000. – Vol. 84. – P. 826–33.
57. Cher I. Blink-related microtrauma: when the ocular surface harms itself // Clin. Experiment. Ophthalmol. – 2003. – Vol. 31. – P. 183–190.
58. Cogan D., Donaldson D., Kuwabara T., Marshall D. Microcystic dystrophy of the corneal epithelium // Trans. Am. Ophthalmol. Soc. – 1964. – Vol. 62. – P. 213-25.
59. Cogan D., Kuwabara T., Donaldson D., et al. Microcystic dystrophy of the cornea. A partial explanation for its pathogenesis // Arch. Ophthal. – 1941. - Vol. 92. – P. 470–474.
60. Creeves R. X-ray applications in superficial keratitis // Trans. Ophthalmol. Soc. UK. – 1930. – Vol. 50. – P. 111-117.
61. Dada V. Contact lens induced filamentary keratitis // Am. J. Optom. Physiol. Opt. – 1975. – Vol. 52. – P. 545-6.
62. Davidson R., Mannis M. Filamentary keratitis. In: Krachner J., Mannis M., Holland E., editors Cornea. – Vol. 1. 3 rd ed. - Philadelphia: Elsevier Mosby. - 2005.
63. De Schweinitz G. Relapsing traumatic bullous keratitis, with cases // Ophthalmol. Rev. – 1902. – Vol. 11. – P. 76-82.
64. Dekaris I., MravicicI., BarisicA. et al. Amniotic membrane transplantation in the treatment of persistent epithelial defect on the corneal graft // Coll. Antropol. – 2010. – Vol. 34. – P. 15-9.
65. Diez-Feijoo E., Grau A., Abusleme E., Duran J. Clinical Presentation and Causes of Recurrent Corneal Erosion Syndrome: Review of 100 Patients // Cornea. – 2014. – Vol. 33 – P. 571-5.
66. Diller R., Sant S. A case report and review of filamentary keratitis // Optometry. – 2005. – Vol. 76. – P. 30–6.
67. Ding M., Burstein N. Fibronectin in corneal wound healing // J. Ocul. Pharmacol. – 1988. – Vol. 4. – P. 75-91.
68. Dohlman C., Bortichoff S., Mobilia E. Complications in use of soft contact lenses in corneal disease // Arch. Ophthalmol. – 1973. – Vol. 90. – P. 367-371.
69. Dua H., Azuara-Blanco. Amniotic membrane transplantation // Br. J. Ophthalmol. – 1999. – Vol. 83. – P. 748–52.
70. Duke-Elder W., Leigh A. System of Ophthalmology // St. Louis, CV Mosby Co. – 1965. – Vol. VIII. – P. 694-697.
71. Dundas M., Walker A., Woods R. Clinical grading of corneal staining of non-contact lens wearers // Ophthal. Physiol. Opt. – 2001. – Vol. 21. – P. 30-5.
72. Dunn S. et al. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4 // Ann. NY Acad. Sci. – 2010. – Vol. 1194. – P. 199-206.
73. Dursun D., Kim M., Solomon A. et al. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids // Am. J. Ophthalmol. – 2001. – Vol. 132. – P. 8-13.
74. Efron N., Morgan P., Katsara S. Validation of grading scales for contact lens complications // Ophthalmic Physiol. Opt. – 2001. – Vol. 21. – P. 17-29.
75. Eschstruth P, Sekundo W. Different treatment options with excimer laser with emphasis on aggressive PTK // Ophthalmologe. – 2006. – Vol. 103. – P. 570-5.
76. Feldman S. The effect of epidermal growth factor on corneal wound healing: practical considerations for therapeutic use // Refract. Corneal Surg. – 1991. – Vol. 7. – P. 232–9.
77. Fischer E. Über Fädchenkeratitis // Graefes Arch. Ophthalmol. – 1889. – Vol. 35. – P. 201–215.
78. Fleischanderl A. Zur Behandlung der rezidivierenden Erosion // Klin. Monatsbl. Augenheilkd. – 1954. – Vol. 125. – P. 747-748.
79. Franceschetti A. Hereditare rezidivierende Erosion der Hornhaut // Z. Augenheilkd. – 1928. - №66. – P. 309-316.
80. Franqois J., Neetons A. Erosion dystrophique recidivante de l’epithelium // Bull. Soc. Belge. Ophthalmol. – 1953. – Vol. 104. – P. 271-288.
81. Fu Y., Liu J., Tseng S. Ocular surface deficits contributing to persistent epithelial defect after penetrating keratoplasty // Cornea. – 2012. – Vol. 31. – P. 723-9.
82. Fujikawa L., Foster C., Harrist T. et al. Fibronectin in healing rabbit corneal wounds // Lab. Incest. – 1981. – Vol. 45. – P. 120-129
83. Fujikawa L., Foster C., Gipson I., Colvin R. Basement membrane components in healing rabbit corneal epithelial wounds: immunofluorescence and ultrastructural studies // J. Cell. Biol. - 1984. – Vol. 98(1). – P. 128–38.
84. Fukuda M., Deai T., Higaki S. et al. Presence of a large amount of herpes simplex virus genome in tear fluid of herpetic stromal keratitis and persistent epithelial defect patients // Semin. Ophthalmol. – 2008. – Vol. 23. – P. 217-20
85. Garrana R., Zieske J., Assouline M. et al. Matrix metalloproteinases in epithelia from human recurrent corneal erosion // Invest. Ophthalmol. Vis. Sci. – 1999. – Vol. 40. – P. 1266-70.
86. Geerling G., Maclennan S., Hartwig D. Autologous serum eye drops for ocular surface disorders // Br. J. Ophthalmol. – 2004. – Vol. 88. – P. 1467–1474.
87. Gifford S. Epithelial dystrophy and recurrent erosion of the cornea as seen with the slit-lamp // Arch. Ophthalmol. – 1925. – Vol. 54. – P. 217-232.
88. Gilbard J., Farris R. Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca // Arch. Ophthalmol. – 1979. – Vol. 97. P. 1642–1646.
89. Goldman J., Dohlman C., Kravitt B. The basement membrane of the human cornea in recurrent epithelial erosion syndrome // Trans. Am. Acad. Ophthalmol. Otolaryngol. – 1969. – Vol. 73(3). – P. 471-81.
90. Golubovic S., Parunovic A. Cyanoacrylate glue in the treatment of corneal ulcerations // Fortschr. Ophthalmol. – 1990. – Vol. 87. – P. 378–81.
91. Grinbaum A., Yassur I., Avni I. The beneficial effect of diclofenac sodium in the treatment of filamentary keratitis // Arch. Ophthalmol. – 2001. – Vol. 119. – P. 926-7.
92. Gumus K., Gire A., Pflugfelder S. The successful use of Boston ocular surface prosthesis in the treatment of persistent corneal epithelial defect after herpes zoster ophthalmicus // Cornea. – 2010. – Vol. 29. – P. 1465-8.
93. Gumus K., Lee S., Yen M. et al. Botulinum toxin injection for the management of refractory filamentary keratitis // Arch. Ophthalmol. – 2012. – Vol. 130. – P. 446-50.
94. Guyard M., Perdreil G. Apropos of the treatment of recurrent erosion of the cornea // Bull. Soc. Ophthalmol. Fr. – 1961. – Vol. 6. – P. 579-82.
95. Hamilton W., Wood T. Filamentary keratitis // Am. J. Ophthalmol. – 1982. – Vol. 93. – P. 466-9.
96. Hammar B., Lagali N., Ek S. et. al. Dystrophia Smolandiensis – recurrent corneal erosions with a novel morphological picture // Acta Ophthalmologica. – 2010. – Vol. 88. – P. 394-400.
97. Hammar B., Björck E., Lind H. et al. Dystrophia Helsinglandica: a new type of hereditary corneal recurrent erosions with late subepithelial fibrosis // Acta Ophthalmol. – 2009. – Vol. 87(6). – P. 659-65.
98. Hansen E. Om den intermitterende keratitis visicularis neuralgica Af traumatisk opindelse // Hospitals-Tidende. – 1872. - №51. – P. 201-203.
99. Hao Y., Hui-Kang D., Hwang D. et al. Identification of antiangiogenic and anti-inflammatory proteins in human amniotic membrane // Cornea. – 2000. – Vol. 19. – P. 348–52.
100. Harker D. A modified Schirmer tear test technique. Its uses in aiding the diagnosis of chronic keratoconjunctivitis sicca (filamentary keratitis) in dogs // Vet. Rec. – 1970. – Vol. 14. – P. 196-9.
101. Haschemi H., Taheri S., Fotouchi A., Kheiltash A. Evaluation of prophylactic use of mitomycin C to inhibit haze formation after PTK in high myopia: a prospective clinical study // BMC Ophthalmol. – 2004. – Vol. 1. – P. 12.
102. Hingorani M., Calder V., Buckley R., Lightman S. The immunomodulatory effect of topical cyclosporine A in atopic keratoconjunctivitis // Invest. Ophthalmol. Vis. Sci. – 1999. – № 40. – P. 392-399.
103. Hirsch C. Über die sogenannt "Recidivierende Erosion der Horuihaut" ulnd ihre Behandlung // Prag. Medizen Wochenschr. – 1898. – Vol. 23. – P. 317-320.
104. Hogan B. Laminin and epithelial cell attachment // Nature. – 1981. – Vol. 290. – P. 737-738.
105. Holland E., Olsen T., Ketcham J. et al. Topical cyclosporine A in the treatment of anterior segment inflammatory disease // Cornea. – 1993. – Vol. 12. – P. 413-419.
106. Hope-Ross M. et al. Recurrent corneal erosion: clinical features // Eye (Lond.). – 1994. – Vol. 8. – P. 373-377.
107. Huang W., Chiang C., Tsai Y. Autologous serum eye drops for treating persistent corneal epithelial defect after vitreoretinal surgery // Cornea. – 2008. – Vol. 27. – P. 1097.
108. Huff T., MÜller C., Otto A., Netzker R., et al. Beta-Thymosins, small acidic peptides with multiple functions // Int. J. Biochem. Cell Biol. – 2001. – Vol. 33(3). – P. 205-220.
109. Hull D., Hvndiuk R., Chin G. et al. Clinical experience with the therapeutic hydrophilic contact lens // Ann. Ophthalmol. – 1975. – Vol. 7. – P. 555-562.
110. Jeng B. Treating the nonhealing epithelial defect - an overview of standard and investigational therapies for persistent corneal epithelial defects // Cataract Refractive Surgery Today Europe. – 2011. – Vol. 9 – P. 25–28.
111. Jengand B., Dupps W. Jr. Autologous serum 50% eye drops in the treatment of persistent corneal epithelial defects. – Cornea. – 2009. - Vol. 28. - P. 1104– 1108.
112. Johnson K., Levin F., Chu D. Persistent corneal epithelial defect associated with erlotinib treatment // Cornea. – 2009. – Vol. 28. – P. 706-7.
113. Jones L., MacDougall N., Sorbara L. Asymptomatic corneal staining associated with the use of balafilcon silicone-hydrogel contact lenses disinfected with a polyaminopropyl biguanide-preserved care regimen // Optom. Vis. Sci. – 2002. – Vol. 79. – P. 753-61.
114. Josephson J., Caffery B. Corneal staining after instillation of topical anesthetic (SSII) // Invest. Ophthalmol. Vis. Sci. – 1988. – Vol. 29. – P. 1096-9.
115. Kakizaki H., Zako M., Mito H. et al. Filamentary keratitis improved by blepharoptosis surgery: two cases // Acta Ophthalmol. – 2003. – Vol. 81. – P. 669–671.
116. Kauffmann E. Klinische Studien zur Frage der rezidivierenden erosion // Klin. Monatsbl. Augenheilkd. – 1907. – Vol. 45. – P. 202-210.
117. Kaufman H., Clower J. Irregularities of Bowman's membrane // Am. J. Ophthalmol. 1966. – Vol. 61. – P. 227-230.
118. Khodadoust A., Silverstein A., Kenyon K. et al. Adhesion of regenerating corneal epithelium: the role of basement membrane // Am. J. Ophthalmol. – 1968. – Vol. 57. – P. 311–7.
119. Kim J. et al. The effect of in vivo growth corneal epithelium transplantation on persistent epithelial defects with limbal stem cell deficiency // J. Korean Med. Sci. – 2008. – Vol. 23. – P. 502-508.
120. Kinoshita S., Yokoi N. Filamentary keratitis. In: Foster CS, Azar DT, Dohlman CH, editors. Smolin and Thoft’s the cornea: scientific foundations and clinical practice. 4. Philadelphia: Lippincott Williams & Wilkins. - 2005.
121. Koizumi N., Inatomi T., Sotozono C. et al. Growth factor mRNA and protein in preserved human amniotic membrane // Curr. Eye Res. – 2000. – Vol. 20. – P. 173–7.
122. Kordic R., Suic S., Jandrokovic S. et al. Application of the amniotic membrane extract (AMX) for the persistent epithelial defect (PED) of the cornea // Coll. Antropol. – 2013. – Vol. 37. – P. 161-4.
123. Kowalik B., Rakes J. Filamentary keratitis–the clinical challenges // J. Am. Optom. Assoc. – 1991. – Vol. 62. – P. 200–4.
124. Kruse F., Rohrschneider K., Volcker H. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers // Ophthalmology. – 1999. – Vol. 106. – P. 1504–11.
125. Laibson P., Krachmer J. Familial occurrences of dot (microcystic), map, fingerprint dystrophy of the cornea // Invest. Ophthalmol. – 1975. - №14. – P. 397-399.
126. Langston R., Machamer C., Norman C. Soft lens therapy for recurrent erosion syndrome // Ann. Ophthalmol. – 1978. – Vol. 10. – P. 875-878.
127. Latessa A., Teng C., Katzin H. The hystochemistry of the basement membrane of the cornea // Am. J. Ophthalmol. – 1954. – Vol. 38(2). – P. 171-7.
128. Leber T. Communication to the XIV congress of the German Soc. Ophthalmol. Heidelberg 1882 // Klin. Monatsbl. Augenheilkd. – 1882. – Vol. 20. – P. 165.
129. Ledbetter S., Hassell J., Kleinman H. et al. Induction of heparin sulfate proteoglycan core protein in differentiating cells in culture // J. Cell. Biol. – 1983. – Vol. 97. – P. 458.
130. Lederman M. Radiotherapie de sulcers de la corneen // J. Belge Radiol. – 1951. – Vol. 34. – P. 450-460.
131. Lee S., Li D., Tan D. et al. Suppression of TGF-a signaling in both normal conjunctival fibroblasts and pterygiual body fibroblasts by amniotic membrane // Curr. Eye Res. – 2000. – Vol. 20. – P. 325–34.
132. Lee S., Tseng S. Amniotic membrane transplantation for persistent epithelial defects with ulceration // Am. J. Ophthalmol. – 1997. – Vol. 123. P. 303–12.
133. Leigh A. Therapeutic keratoplasty // Trans. Ophthalmol. Soc. UK. – 1959. – Vol. 79. – P. 439-452.
134. Lekhanont K., Jongkhajornpong P., Choubtum L. et al. Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery // Biomed. Res. Int. – 2013. Vol. 52. – P. 13-15.
135. Lemp M. Report of the National Eye Institute/Industry workshop on clinical trials in Dry Eyes // CLAO J. – 1995. – Vol. 21. – P. 221–32.
136. Li X., Hu L., Hu J. et al. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery // Cornea. – 2007. – Vol. 26. – P. 16–20.
137. Li X., Zhang J., Wang W. Application of lacrimal plug for dry eye patients // Zhonghua Yan Ke Za Zhi. – 2005. – Vol. 41. – P. 1098–1102.
138. Liebman S. An unusual case of filamentary keratitis // AMA Arch. Ophthalmol. – 1955. – Vol. 54. – P. 434-5.
139. Ling J., Gire A., Pflugfelder S. PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects // Am. J. Ophthalmol. – 2013. – Vol. 155. – P. 615-619.
140. Lopin E., Deveney T., Asbell P. Impression cytology: recent advances and applications in dry eye disease. Review // Ocul. Surf. – 2009. – Vol. 7. – P. 93–110.
141. Lowe R. Recurrent erosion of the cornea // Br. J. Ophthalmol. – 1970. – Vol. 54. – P. 805-9.
142. Lugo M., Arentsen J. Treatment of neurotrophic ulcers with conjunctival flaps // Am. J. Ophthalmol. – 1987. – Vol. 103. – P. 711–2.
143. Lv H., Liu Z., Li X. et al. Effect of lacrimal plugs combined with deproteinized calf blood extract eye gel for filamentary keratitis // J. Ocul. Biol. Dis. Infor. – 2010. – Vol. 3. – P. 134-40.
144. Ma Y., Zhao S., Wang X. et al. A New Recombinant PACAP-Derived Peptide Efficiently Promotes Corneal Wound Repairing and Lacrimal Secretion // Invest. Ophthalmol. Vis. Sci. – 2015. – Vol. 56(8). – P. 4336-49.
145. Macaluso D., Feldman S. Pathogenesis of sterile corneal erosions and ulcerations. In: Krashmer JH, Mannis MJ, Holland EJ, eds. Cornea, fundamentals and cornea and external disease. Missouri: Mosby. - 1997. – P. 204–5.
146. Malinda K., Sidhu G., Mani H. et al. Thymosin beta4 accelerates wound healing // J. Invest. Dermatol. 1999. – Vol. 113(3). – P. 364-368.
147. Maudgal P., Missotten L., Van Deuren H. Study of filamentary keratitis by replica technique // Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. – 1979. – Vol. 2. – P. 11-21.
148. McDonald J., Broekelmann T., Kelley D. et al. Monoclonal antibody to fibronectin's cell adhesive site prevents extracellular matrix formation // J. Cell. Biol. – 1983. – Vol. 97. – P. 3
149. McLean E. et al. Recurrent erosion. Treatment by anterior stromal puncture // Ophthalmology. – 1986. – Vol. 93. – P. 746-8.
150. McNabb H. Recurring erosion of the cornea // Trans. Ophthalmol. Soc. UK. - 1933. Vol. 53. – P. 600-601.
151. Meighan S. Two cases of relapsing traumatic vesicular keratitis // Trans. Ophthalmol. Soc. UK. – 1924. – Vol. 44. – P. 46-56.
152. Menzies J. Detachment of corneal epithelium // Ophthalmol. Rev. - 1902. – Vol. 21. – P. 221-226.
153. Mobilia E., Dohlman C., Holly F. A comparison of various soft contact lenses for therapeutic purposes // Contact Intraoc. Lens. Med. J. – 1977. – Vol. 3. – P. 9-15.
154. Murube J., Nemeth J., Höh H. et al. The triple classification of dry eye for practical clinical use // Eur. J. Ophthalmol. – 2005. – Vol. 15(6). – P. 660-7.
155. Na B., Hwang J., Shin E. et al. Analysis of human amniotic membrane components as proteinas inhibitors for development of therapeutic agent of recalcitrant keratitis // Invest. Ophthalmol. Vis. Sci. – 1998. – Vol. 39. – P. 90.
156. Nakamura T., Inatomi T., Sotozono C. et al. Ocular surface reconstruction using stem cell and tissue engineering // Prog. Retin. Eye Res. – 2016. – Vol. 51. – P. 187-207.
157. Newsome D., Gross J. Prevention by medroxyprogesterone of perforation in the alkali-burned rabbit cornea: inhibition of collagenolytic activity // Invest. Ophthalmol. Vis. Sci. – 1977. – Vol. 16. – P. 21–31.
158. Nichols K., Mitchell G., Simon K. et al. Corneal staining in hydrogel lens wearers // Optom. Vis. Sci. – 2002. – Vol. 79. – P. 20-30.
159. Nishida T., Nakagawa S., Manabe R. Clinical evaluation of fibronectin eyedrops on epithelial disorders after herpetic keratitis // Ophthalmology. – 1985. – Vol. 92. – P. 213–6.
160. Noble B., Loh R., MacLennan S. et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease // British Journal of Ophthalmology. - 2004. - Vol. 88. - P. 647– 652.
161. Obenberger, J. Paper strips and rings as simple tools for standardization of experimental eye injuries / J. Obenberger // Ophthalmol. Res. – 1975. – Vol.7. – P. 363–366.
162. Ormonde S., Chou C., Goold L. et al. Regulation of connexin43 gap junction protein triggers vascular recovery and healing in human ocular persistent epithelial defect wounds // J. Membr. Biol. – 2012. – Vol. 245. – P. 381-8.
163. Oskouee S., Amuzadeh J., Rajabi M. Bandage contact lens and topical indomethacin for treating persistent corneal epithelial defects after vitreoretinal surgery // Cornea. – 2007. – Vol. 26. – P. 1178-81.
164. Ozturk F., Inan U. The effects of acetylcholine and propolis extract on corneal epithelial wound healing in rats // Cornea. – 1999. – Vol. 18. – P. 466–471.
165. Pal-Ghosh S., Pajoohesh-Ganji A., Brown M. et al. A mouse model for the study of recurrent corneal epithelial erosions: alpha9beta1 integrin implicated in progression of the disease // Invest. Ophthalmol. Vis. Sci. – 2004. – Vol. 45. – P. 1775-88.
166. Park W., Tseng S. Temperature cooling reduces keratocyte death in excimer laser ablated corneal and skin wounds // Invest. Ophthalmol. Vis. Sci. – 1998. – Vol. 39. – P. 449.
167. Peters A. Uber Traumatische Hornhauterkrankungen und ihre Beziehungen zum Herpes corneae // Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. – 1904. – Vol. 57. – P. 93-137
168. Pfister R. The normal surface of corneal epithelium: a scanning electron microscopic study // Invest. Ophthalmol. (Copenh). – 1973. – Vol. 12(9). – P. 654–68.
169. Pfister R., Haddox J., Dadson R. et al. Polymorphonuclear leukocytic inhibition by citrate, other metal chelators, and trifluoperazine // Invest. Ophthalmol. Vis. Sci. – 1984. – Vol. 25. – P. 955–70.
170. Prabhasawat P., Barton K., Burkett G. et al. Comparison of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision // Ophthalmology. – 1997. – Vol. 104. – P. 974–85.
171. Prabhasawat P., Kosrirukvong P., Booranapong W. et al. Application of preserved human amniotic membrane for corneal surface reconstruction // Cell Tis. Bank. – 2000. – Vol. 1. P. 213–22.
172. Qiu C., Coutinho P., Frank S. et al. Targeting connexin43 expression accelerates the rate of wound repair // Curr. Biol. – 2003. – Vol. 13(19). – P. 1697-1703.
173. Ralph R., Doane M., Dohlman C. Clinical experience with a mobile ocular perfusion pump // Arch. Ophthalmol. – 1975. -Vol. 93(10). - P. 1039–1043.
174. Rea L. Case of filamentary keratitis // Proc. R. Soc. Med. – 1922. – Vol. 15 (Sect. Ophthalmol). – P. 17.
175. Reuss A. Über rezidivierende traumatische Erosionen der Hornhaut // Prag. Medizen Wochenschr. – 1898. – Vol. 21. – P. 243-245.
176. Ricci F., Missiroli F., Ciotti M. et al. Persistent epithelial defect after penetrating keratoplasty caused by adenoviral infectious keratitis // New Microbiol. – 2010. – Vol. 33. – P. 171-4.
177. Ronci C., Ferraro A., Lanti A. et al. Platelet-rich plasma as treatment for persistent ocular epithelial defects // Transfus. Apher. Sci. – 2015. – Vol. 52. – P. 300-4.
178. Rougier M. A propos d'un cas d'erosion recidivante de la cornee // Bull. Soc. Ophthalmol. Fr. – 1953. – Vol. 00. – P. 635-637.
179. Ryan G., Lee G., Maccheron L. Epithelial debridement with diamond burr superficial keratectomy for the treatment of recurrent corneal erosion. // Clin. Experiment Ophthalmol. - 2013. – Vol. 41. – P. 621-2.
180. Sage H. Collagens of basement membranes // J. Invest. Dertmtatol. – 1982. – Vol. 79. – P. 51-59.
181. Santodomingo-Rubido J., Wolffsohn J., Gilmartin B. Changes in ocular physiology, tear film characteristics, and symptomatology with 18 months silicone hydrogel contact lens wear // Optom. Vis. Sci. – 2006. – Vol. 83. – P. 73-81.
182. Sayegh R. et al. Cocaine-assisted epithelial debridement for the treatment of anterior basement membrane dystrophy // Cornea. – 2013. – Vol. 32. – P. 889-92.
183. Schall Klin. Monatsbl. F. Augenh. – 1930. – lxxxv. - P. 406.
184. Schreiber L. Die Behandlung der rezidivierenden Hornhauterosionen mit Scharlachsalbe // Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. – 1914. – Vol. 87. – P. 174-184.
185. Schwallie J., McKenney C., Long B., McNeil A. Corneal staining patterns in normal non-contact lens wearers // Ophthal. Physiol. Opt. – 2001. – Vol. 21. – P. 30-5.
186. Shimazaki J., Hao-Yang Y., Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns // Ophthalmology. – 1997. – Vol. 104. – P. 2068–76.
187. Shimazaki J., Shinozaki I., Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon // Br. J. Ophthalmol. – 1998. – Vol. 82. – P. 235–40.
188. Sjögren H. Zur Kenntnis der Keratoconjunctivitis Sicca (Keratitis filiformis bei Hypofunktion der TränendrÜsen) // Acta Ophthalmol. -1933. - Vol. 2. – P. 1–151.
189. Sonnenberg A., Calafat J., Janssen H. et al. Integrin a6/b4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion // J. Cell. Biol. – 1991. – Vol. 113. – P. 907–17.
190. Spigelman A., Deutsch T., Sugar J. Application of homologous fibronectin to persistent human corneal epithelial defects // Cornea. – 1987. – Vol. 104. – P. 494– 501.
191. Stanley J., Woodley D., Katz S. et al. Structure and function of basement membrane // J. Invest. Dermatol. – 1982. – Vol. 79. – P. 69-72.
192. Stood W. Über rezidivierende Blasenbildungen auf der Hornhaut des Auges und Keratalgien nach Verletzungen der Hornhautoberflache // Arch. Augenheilkd. – 1901. Vol. 43. – P. 220-228.
193. Su C., Lin C. Combined use of an amniotic membrane and tissue adhesive in treating corneal perforation: a case report // Ophthalmic Surg. Lasers. – 2000. – Vol. 31. – P. 151–4.
194. Sugruie S., Hay E. Response of basal epithelial cell surface and cytoskeleton to solubilized extracellular matrix molecules // J. Cell. Biol. – 1981. – Vol. 91. – P. 45-54
195. Szili A. Über Disjuinction des Hornhaut Epithels // Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. – 1900. - №51. – P. 486-531.
196. Tabery H. Filamentary keratopathy: a non-contact photomicrographic in vivo study in the human cornea // Eur. J. Ophthalmol. – 2003. – Vol. 13. – P. 599–605.
197. Tanioka H., Yokoi N., Komuro A. et al. Investigation of the corneal filament in filamentary keratitis // Invest. Ophthalmol. Vis. Sci. – 2009. – Vol. 50. – P. 3696-702.
198. Teng C. Fine structure of the human cornea: epithelium and stroma // Am. J. Ophthalmol. – 1962. – Vol. 19. – P. 1094-7.
199. Terry R., Schnider C., Holden B. et al. CCLRU standards for success of daily and extended wear contact lenses // Optom. Vis. Sci. – 1993. – Vol. 70. – P. 23-43.
200. Thakrar R. et al. Treatment of recurrent corneal erosions // Eyenet. – 2013. Vol. 1. – P. 39-41.
201. Theodore F. Filamentary keratitis // Contact. Intraocul. Lens Med. J. – 1982. – Vol. 8. – P. 138-46.
202. Theodore F. The use of tension-lowering drugs and other aids in the management of recurrent corneal erosions // Eye Ear Nose Throat Mon. – 1964. – Vol. 43. – P. 62-4.
203. Theophanous C., Parker P., Chiu GB. et al. Use of Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lenses in Patients with Ocular Chronic Graftversus-Host Disease // Biol. Blood Marrow Transplant. – 2015. – Vol. 21(12). – P. 2180-4
204. Thiel HJ, Behnke H. Eine bisher unbekannte subepitheliale hereditäre Hornhautdystrophie. Klin Monatsbl Augenheilkd. – 1967. – Vol. 150. – P. 862–874.
205. Thoft R., Mobilia E. Complications with therapeutic extended wear soft contact lenses // Int. Ophthalmol. Clin. – 1981. – Vol. 21. – P. 197-208.
206. Thygeson P. Observations on recurrent erosion of the cornea // Am. J. Ophthalmol. – 1959. – Vol. 47(5). – P. 155-70.
207. Timpl R., Engel J., Martin G. Laminin - A multifunctional protein of basement membranes // Tr. Biochem. Sci. – 1983. – Vol. 8. – P. 207-209.
208. Timpl R., Rohde H. Laminin – A glycoprotein from basement membranes // J. Cell. Biol. – 1979. – Vol. 254. – P. 9933-9937.
209. Tripathi R., Bron A. Ultrastructural study of non-traumatic recurrent corneal erosion // Br. J. Ophthalmol. – 1972. – Vol. 56. – P. 73-85.
210. Trobe J., Laibson P. Dystrophic changes in the anterior cornea // Arch. Ophthalmol. – 1972. – Vol. 87(4). – P. 378-82.
211. Tseng S., Li D., Ma X. Suppression of transforming growth factor beta isoforms, TGF-a receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix // J. Cell. Physiol. – 1999. – Vol. 179. – P. 325–35.
212. Tseng S., Prabhasawat P., Barton K. et al. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency // Arch. Ophthalmol. – 1998. - Vol. 116. P. 431–41.
213. Tseng S., Prabhasawat P., Lee S. Amniotic membrane transplantation for conjunctival surface reconstruction // Arch. Ophthalmol. – 1997. – Vol. 124. – P. 765– 74.
214. Tseng S., Tsubota K. Important concepts for treating ocular surface and tear disorders // Am. J. Ophthalmol. – 1997. – Vol. 124. – P. 825–35.
215. Tsubota K., Goto E., Fujita H. et al. Treatment of dry eye by autologous serum application in Sjogren’s syndrome // British Journal of Ophthalmology. – 1999. -Vol. 83. - P. 390–395.
216. Tsubota K., Goto E., Shimmura S. et al. Treatment of persistent corneal epithelial defect by autologous serum application // Ophthalmology. – 1999. - Vol. 106. - P. 1984–1989.
217. Tsubota K., Satake Y., Ohyama M. et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome // Am. J. Ophthalmol. – 1996. – Vol. 122. – P. 38–52.
218. Ubels J., McCartney M., Lantz W. et al. Effects of preservative-free artificial tear solutions on corneal epithelial structure and function // Arch. Ophthalmol. – 1995. – Vol. 113. – P. 371–378.
219. Valle O. Heridetary recurring corneal erosions a familial study with special reference to Fuchs’ dystrophy // Acta Ophthalmol. – 1967. – Vol. 45. – P. 829-836.
220. Verhoeff F. Neuropathic keratitis and some allied conditions with special reference to treatment // J. Am. MedAssoc. – 1909. – Vol. 53. – P. 191-198.
221. Vogt A. Lehrbuch und Atlas der Spaltlampenmikroskopie des lebenden Auges, 2 ed. Springer, Berlin. - 1930. – Vol. 1. – P. 246.
222. Wagenmanin X. Über rezidivierende erosionen der Kornea // MÜnchen Medizen Wochenschr. – 1904. – Vol. 2. – P. 93-95.
223. Wales H. A family history of corneal erosion // Trans. Ophthalmol. Soc. NZ. – 1955. - №8. – P. 77-78.
224. Weiss J., Moller H., Aldave A. et al. IC3D classification of corneal dystrophies – edition 2 // Cornea. – 2015. – Vol. 34. – P. 117-59.
225. Welch C., Baum J. Tarsorrhaphy for corneal disease in patients with rheumatoid arthritis // Ophthalmic Surg. – 1988. – Vol. 19. – P. 31–2.
226. Weskamp C. Parenchymatous origin of filamentary keratitis; new histopathologic concepts // Am. J. Ophthalmol. – 1956. – Vol. 42. – P. 115-20.
227. Whitcher J., Shiboski C., Shiboski S. et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from Sjögren’s syndrome international registry // Am. J. Ophthalmol. – 2010. – Vol. 149(3). – P. 405-415.
228. Williams R., Buckley R. Pathogenesis and treatment of recurrent erosion // Br. J. Ophthalmol. – 1985. – Vol. 69(6). – P.435-7.
229. Willis R., Folberg R., Krachmer J., Holland E. The treatment of aqueousdeficient dry eye with removable punctal plugs. A clinical and impression-cytologic study // Ophthalmology. – 1987. – Vol. 94(5). – P. 514-8.
230. Wirostko B., Rafii M., Sullivan D. et al. Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone // Ocul. Surf. – 2015. – Vol. 13. – P. 204-212.
231. Wolffsohn J. Incremental nature of anterior eye grading scales determined by objective image analysis // Br. J. Ophthalmol. – 2004. – Vol. 88. – P. 1434-8.
232. Wood T. Reccurrent erosion // Tr. Am. Ophth. Soc. – 1984. – Vol. LXXXII. – P. 850-898.
233. Wright P. Filamentary keratitis // Trans. Ophthalmol. Soc. UK. – 1975. – Vol. 95. – P. 260-6.
234. Wu W., Zeng L., Peng Y. et al. The effects of recombinant human epithelialgrowth factor and protein-free calf blood extract for recovery of corneal mechanical epithelial defects healing and neovascularization // Eur. Rev. Med. Pharmacol. Sci. – 2014. – Vol. 18. – P. 3406-11.
235. Yee R., Sullivan L., Lai H. et al. Linkage mapping of Thiel-Behnke corneal dystrophy (CDB2) to chromosome 10q23-q24 // Genomics. – 1997. – Vol. 46. – P. 152– 154.
236. Yoon K. Use of umbilical cord serum in ophthalmology // Chonnam. Med. J. - 2014. - Vol. 50. – P. 82-5.
237. Yow H.,Walker E., Song J. et al. Characterization and effects of highly purified fibronectin matrices // J. Cell. Biol. (Abstr.). – 1983. – Vol. 97. – P. 325.
238. Zaidman G., Geeraets R., Paylor R. e al. The histopathology of filamentary keratitis //Arch. Ophthalmol. – 1985. – Vol. 103. – P. 1178-81.
239. Ziakas N. et al. Long-term follow up of autologous serum treatment for recurrent corneal erosions // Clin. Experiment. Ophthalmol. – 2010. – Vol. 38. – P. 683-7.
2. Бржеский В.В., Егорова Г.Б., Егоров Е.А. Синдром «сухого глаза» и заболевания глазной поверхности: клиника, диагностика, лечение // Бржеский В.В., Егорова Г.Б., Егоров Е.А. - М.: ГЭОТАР-медиа, 2016. – 448 с.
3. Бржеский В.В., Сомов Е.Е. Клиническая диагностика и лечение больных с сухим кератоконъюнктивитом на почве синдрома Cъегрена // Офтальмохирургия и терапия. - 2001. - № 1. - С.42-46.
4. Горбунова К.С. Регулирование фибропластических процессов в склеральной ране при помощи сульфатированных гликозаминогликанов: Дис. … канд. мед. наук. - М., 2013. - 121 с.
5. Егорова Г.Б., Фёдоров А.А., Митичкина Т.С., Шамсудинова А.Р., Сафонова Т.Р. Влияние слёзозаместительной и корнеопротекторной терапии на состояние глазной поверхности при синдроме «сухого глаза» // РМЖ. Клин. Офтальмол. – 2015. - №1. – С. 4.
6. Канюков В.Н., Стадников А.А., Трубина О.М., Яхина О.М. Аппликация биопластического материала«Гиаматрикс» при заболеваниях роговицы// Вестник ОГУ. - 2013. - №4. - С. 243-235.
7. Каспарова Е.А., Каспаров А.А., Марченко Н.Р. Рецидивирующая эрозия роговицы: диагностика и лечение // Вестник офтальмологии. – 2010. – №126(5). – С.3-8.
8. Кучеренко А.М., Пампуха В.М., Дрожина Г.И., Лившиц Л.А. Роль полиморфизма генов ИЛ1бета, ИЛ6 и ИЛ8 в развитии рецидивирующей эрозии роговицы у пациентов с наследственными стромальными дистрофиями роговицы // Цитол. Генет. – 2013. - №47(3). – С.42-45.
9. Литвак Г.Ю., Баринов А.В., Комаров В.В., Тюнина Г.К. с соавт. Трансплантация первичной культуры островковой ткани ксеногенной поджелудочной железы больным сахарным диабетом // Технологии живых систем. - 2010. - Т. 7. - No 1. - С. 19-27.
10. Майчук Д.Ю. Рецидивирующие эрозии роговицы: особенности возникновения и лечения// Новое в офтальмологии. – 2014. - №3. – С. 72-75
11. Майчук Д.Ю. Эрозии роговицы: клинические формы, новые методы лечения // РМЖ«Клиническая офтальмология». – 2004. – No1. – C.17.
12. Панасюк А.Ф., Ларионов Е.В. Хондроитинсульфаты и их роль в обмене хондроцитов и межклеточного матрикса хрящевой ткани // Науч.-практ. ревматология. - 2010. - №3. - С. 104-108
13. Перова Н.В., Порунова Ю.В., Урьяш В.Ф., Фаминская Л.А. с соавт. Биодеградируемый коллагенсодержащий матрикс СферогельТМ для клеточной трансплантации// Перспективные материалы. – 2004. – No 2. – С. 52-59.
14. Покровский В.И., Брико Н.И. Общая эпидемиология с основами доказательной медицины. Руководство к практическим занятиям // Покровский В.И., Брико Н.И., Бражников А.Ю., Кирьянова Е.В. с соавт. - М.: ГЭОТАР-медиа, 2010. – 400с.
15. Сайковский Р.С., Савенкова Н.А., Аверьянов А.В., Лисица А.В. Эффективность применения препарата Сферогель для лечения гонартроза // Клиническая практика. - 2013. - №3. - С. 4-10.
16. Севастьянов В.И., Перова Н.В. Биополимерный гетерогенный гидрогель СфероГель – инъекционный биодеградируемый имплантат для заместительной и регенеративной медицины// Практическая медицина. – 2014. -№8(84). – С. 110-116.
17. Севастьянов В.И., Перова Н.В., Немец Е.А. с соавт. Биополимерные матриксы в тканевой инженерии // Сборник тезисов V Всероссийского симпозиума с международным участием «Актуальные вопросы тканевой и клеточной трансплантологии, Изд-во«Башкортостан», Уфа. - 2012. – С.198 - 199.
18. Севастьянов В.И., Перова Н.В., Сайковский Р.С., Соловьева И.В. Применение инъекционных форм биополимерных гетерогенных гидрогелей при дегенеративно-дистрофических поражениях суставов. Практическое пособие для врачей. - Москва: Триада, 2012. – С. 27.
19. Сулеева Б.О. Дикамбаева М.К., Асанова А.А. с соавт. Способ лечения эпителиальных дефектов роговицы // Вестник КРСУ - 2008. – том 8. - №4. – С.124-126.
20. Тонаева Х.Д. Лимбальная сотрансплантация в профилактике отторжения донорских роговиц при кератопластике высокого риска: Дисс. … канд. мед. наук. – М., 2014.
21. Труфанов С.В., Маложен С.А., Полунина Е.Г., Пивин Е.А., Текеева Л.Ю. Синдром рецидивирующей эрозии роговицы (обзор) // Офтальмология. – 2015. – Т. 12. - №2. – С. 4-12.
22. Федяков А.Г., Древаль О.Н., Кузнецов А.В., Севастьянов Ф.И. с соавт. Экспериментальное обоснование применения гелевого имплантата «Сферо®Гель» и пленочного имплантата «ЭластоПОБ®» при травме периферической нервной системы в эксперименте// Вестник трансплантологии и искусственных органов. - 2009. - Т. XI. - No 4. - С. 75-80.
23. Шумаков В.И., Севастьянов В.И. Биополимерные матриксы для искусственных органов и тканей// Здравоохранение и медицинская техника. - №4. – 2003. - C. 30-33.
24. Яхина О.М. Влияние наноструктурированного биополимера гиалуроновой кислоты на течение репаративного процесса роговицы: Дис. … канд. мед. наук. - М., 2013. – С. 131.
25. Agorogiannis G., Alexaki V., Castana O. et al. Topical application of autologous adipose-derived mesenchymal stem cells (MSCs) for persistent sterile corneal epithelial defect // Graefes. Arch. Clin. Exp. Ophthalmol. – 2012. – Vol. 250. – P. 455-7.
26. Albietz J., Sanfilippo P., Troutbeck R. et al. Management of filamentary keratitis associated with aqueous-deficient dry eye // Optom. Vis. Sci. – 2003. – Vol. 80. – P. 420–30.
27. Albietz J., Bruce A. The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments // J. Curr. Eye Res. – 2001. – Vol. 22. – P. 8–18.
28. Alio J., Rodriguez A., Wrobel Dudzinska D. Eye platelet-rich plasma in the treatment of ocular surface disorders // Curr. Opin. Ophthalmol. – 2015. – Vol. 26. – P. 325-32.
29. Andrasko G., Ryen K. Corneal staining and comfort observed with traditional and silicone hydrogel lenses and multipurpose solution combinations // Optometry. – 2008. – Vol. 79. – P. 444–454.
30. Arlt von F. Über die Verletzungen des Auges in Gerichtsarztlicher Beziehung // Wien Medizin Wochenschr. – 1874. – Vol. 23. – P. 447-449.
31. Avisar R., Robinson A., Appel I. et al. Diclofenac sodium, 0.1% (Voltaren Ophtha), versus sodium chloride, 5%, in the treatment of filamentary keratitis. // Cornea. – 2000. – Vol. 19. – P. 145-7.
32. Barr J., Schechtman K., et al. Corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: baseline prevalence and repeatability of detection // Cornea. – 1999. – Vol. 18(1). – P. 34-46.
33. Beetham W. Filamentary Keratitis // Trans. Am. Ophthalmol. Soc. – 1935. – Vol. 33. – P. 413-35.
34. Begley C., Barr J., Edrington T. et al. Characteristics of corneal staining in hydrogel lens wear // Optom. Vis. Sci. – 1996. – Vol. 73. – P. 193-200.
35. Berman M. The pathogenesis of corneal epithelial defects // Acta Ophthalmol. – 1989. – Vol. 67. – P. 55–64.
36. Bieti G. Cheratite bollosa come rara complicanza post-operatoria dopo estrazione di catarratta // Boll. d'Ocul. – 1937. – Vol. 16. – P. 793-807.
37. Bloomfield S., Gasset A., Forstot S. et al. Treatment of filamentary keratitis with the soft contact lens // Am. J. Ophthalmol. – 1973. – Vol. 76. – P. 978-80.
38. Botella A., Marques J., Marques K. et al. Effectiveness of 100% autologous serum drops in ocular surface disorders // Farmacia Hospitalaria. - 2011. -Vol. 35. – P. 8–13.
39. Boudreau N., Sympson C., Werb Z. et al. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix // Science. - 1995. – Vol. 267. – P. 891–3.
40. Boudreau N., Werb Z., Bissell M. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle // Proc. Natl. Acad. Sci. USA. – 1996. – Vol. 93. – P. 3500–13.
41. Brijacak N., Dekaris I., Gagro A. et al. Therapeutic effect of amniotic membrane in persistent epithelial defects and corneal ulcers in herpetic keratitis // Coll. Antropol. – 2008. – Vol. 32. – P. 21-5.
42. Brodrick J., Dark A., Peace W. Fingerprint dystrophy of the cornea. A histologic study // Arch. Ophthal. – 1974. – Vol. 92. – P. 483-489.
43. Bron A. Diagnosis of dry eye // Survey of ophthalmology. – 2001. - Vol. 45. – P. 221-226.
44. Bron A., Brown N. Some superficial corneal disorders // Trans. Ophthalmol. Soc. UK. – 1971. – Vol. 91. – P. 13.
45. Bron A., Burgess S. Inherited recurrent corneal erosion // Trans. Ophthalmol. Soc. UK. – 1981. – Vol. 101. – P. 239-43.
46. Bron A., Evans V., Smith J. Grading of corneal and conjunctival staining in the context of other dry eye tests // Cornea. - 2003. – Vol. 22(7). – P. 640-50.
47. Bron A., Tripathi R. Cogan’s epithelial microcystic dystrophy: a clinicopathological study // Exp. Eye Res. – 1973. – Vol. 17(4). – P. 398.
48. Bronner A. On some cases of traumatic keratalgia // Trans. Ophthalmol. Soc. UK. – 1889. – Vol. 9. – P. 89-94.
49. Brown N., Bron A. Recurrent erosion of the cornea // Br. J. Ophthalmol. – 1976. – Vol. 60. – P. 84-96.
50. Brown S., Lamberts D., Reid T. et al. Neurotrophic and anhidrotic keratopathy treated with substance P and insulinlike growth factor I // Arch. Ophthalmol. – 1997. – Vol. 115. – P. 926–7.
51. BrÜckner A. Kurze Mitteilungen. II Rezidivierende Erosion. – Ophthalmologica, Basel. – 1950. – P. 38-43.
52. Carnt N., Jalbert I., Stretton S. et al. Solution toxicity in soft contact lens daily wear is associated with corneal inflammation // Optometry and Vision Sci. – 2007. – Vol. 84. – P. 309-315.
53. Chan E. et al. A randomized controlled trial of alcohol delamination and phototherapeutic keratectomy for the treatment of recurrent corneal erosion syndrome // Br. J. Ophthalmol. – 2014. – Vol. 98. – P. 166-71.
54. Chandler P. Recurrent erosion of the cornea // Am. J. Ophthalmol. – 1945. – Vol. 28. – P. 355-363.
55. Chandler P. Recurrent erosion of the cornea // Trans. Am. Ophthalmol. Soc. – 1944. – Vol. 42. – P. 355-7.
56. Chen H., Pires T., Tseng S. Amniotic membrane transplantation for severe neurotrophic corneal ulcers // Br. J. Ophthalmol. – 2000. – Vol. 84. – P. 826–33.
57. Cher I. Blink-related microtrauma: when the ocular surface harms itself // Clin. Experiment. Ophthalmol. – 2003. – Vol. 31. – P. 183–190.
58. Cogan D., Donaldson D., Kuwabara T., Marshall D. Microcystic dystrophy of the corneal epithelium // Trans. Am. Ophthalmol. Soc. – 1964. – Vol. 62. – P. 213-25.
59. Cogan D., Kuwabara T., Donaldson D., et al. Microcystic dystrophy of the cornea. A partial explanation for its pathogenesis // Arch. Ophthal. – 1941. - Vol. 92. – P. 470–474.
60. Creeves R. X-ray applications in superficial keratitis // Trans. Ophthalmol. Soc. UK. – 1930. – Vol. 50. – P. 111-117.
61. Dada V. Contact lens induced filamentary keratitis // Am. J. Optom. Physiol. Opt. – 1975. – Vol. 52. – P. 545-6.
62. Davidson R., Mannis M. Filamentary keratitis. In: Krachner J., Mannis M., Holland E., editors Cornea. – Vol. 1. 3 rd ed. - Philadelphia: Elsevier Mosby. - 2005.
63. De Schweinitz G. Relapsing traumatic bullous keratitis, with cases // Ophthalmol. Rev. – 1902. – Vol. 11. – P. 76-82.
64. Dekaris I., MravicicI., BarisicA. et al. Amniotic membrane transplantation in the treatment of persistent epithelial defect on the corneal graft // Coll. Antropol. – 2010. – Vol. 34. – P. 15-9.
65. Diez-Feijoo E., Grau A., Abusleme E., Duran J. Clinical Presentation and Causes of Recurrent Corneal Erosion Syndrome: Review of 100 Patients // Cornea. – 2014. – Vol. 33 – P. 571-5.
66. Diller R., Sant S. A case report and review of filamentary keratitis // Optometry. – 2005. – Vol. 76. – P. 30–6.
67. Ding M., Burstein N. Fibronectin in corneal wound healing // J. Ocul. Pharmacol. – 1988. – Vol. 4. – P. 75-91.
68. Dohlman C., Bortichoff S., Mobilia E. Complications in use of soft contact lenses in corneal disease // Arch. Ophthalmol. – 1973. – Vol. 90. – P. 367-371.
69. Dua H., Azuara-Blanco. Amniotic membrane transplantation // Br. J. Ophthalmol. – 1999. – Vol. 83. – P. 748–52.
70. Duke-Elder W., Leigh A. System of Ophthalmology // St. Louis, CV Mosby Co. – 1965. – Vol. VIII. – P. 694-697.
71. Dundas M., Walker A., Woods R. Clinical grading of corneal staining of non-contact lens wearers // Ophthal. Physiol. Opt. – 2001. – Vol. 21. – P. 30-5.
72. Dunn S. et al. Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4 // Ann. NY Acad. Sci. – 2010. – Vol. 1194. – P. 199-206.
73. Dursun D., Kim M., Solomon A. et al. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline and corticosteroids // Am. J. Ophthalmol. – 2001. – Vol. 132. – P. 8-13.
74. Efron N., Morgan P., Katsara S. Validation of grading scales for contact lens complications // Ophthalmic Physiol. Opt. – 2001. – Vol. 21. – P. 17-29.
75. Eschstruth P, Sekundo W. Different treatment options with excimer laser with emphasis on aggressive PTK // Ophthalmologe. – 2006. – Vol. 103. – P. 570-5.
76. Feldman S. The effect of epidermal growth factor on corneal wound healing: practical considerations for therapeutic use // Refract. Corneal Surg. – 1991. – Vol. 7. – P. 232–9.
77. Fischer E. Über Fädchenkeratitis // Graefes Arch. Ophthalmol. – 1889. – Vol. 35. – P. 201–215.
78. Fleischanderl A. Zur Behandlung der rezidivierenden Erosion // Klin. Monatsbl. Augenheilkd. – 1954. – Vol. 125. – P. 747-748.
79. Franceschetti A. Hereditare rezidivierende Erosion der Hornhaut // Z. Augenheilkd. – 1928. - №66. – P. 309-316.
80. Franqois J., Neetons A. Erosion dystrophique recidivante de l’epithelium // Bull. Soc. Belge. Ophthalmol. – 1953. – Vol. 104. – P. 271-288.
81. Fu Y., Liu J., Tseng S. Ocular surface deficits contributing to persistent epithelial defect after penetrating keratoplasty // Cornea. – 2012. – Vol. 31. – P. 723-9.
82. Fujikawa L., Foster C., Harrist T. et al. Fibronectin in healing rabbit corneal wounds // Lab. Incest. – 1981. – Vol. 45. – P. 120-129
83. Fujikawa L., Foster C., Gipson I., Colvin R. Basement membrane components in healing rabbit corneal epithelial wounds: immunofluorescence and ultrastructural studies // J. Cell. Biol. - 1984. – Vol. 98(1). – P. 128–38.
84. Fukuda M., Deai T., Higaki S. et al. Presence of a large amount of herpes simplex virus genome in tear fluid of herpetic stromal keratitis and persistent epithelial defect patients // Semin. Ophthalmol. – 2008. – Vol. 23. – P. 217-20
85. Garrana R., Zieske J., Assouline M. et al. Matrix metalloproteinases in epithelia from human recurrent corneal erosion // Invest. Ophthalmol. Vis. Sci. – 1999. – Vol. 40. – P. 1266-70.
86. Geerling G., Maclennan S., Hartwig D. Autologous serum eye drops for ocular surface disorders // Br. J. Ophthalmol. – 2004. – Vol. 88. – P. 1467–1474.
87. Gifford S. Epithelial dystrophy and recurrent erosion of the cornea as seen with the slit-lamp // Arch. Ophthalmol. – 1925. – Vol. 54. – P. 217-232.
88. Gilbard J., Farris R. Tear osmolarity and ocular surface disease in keratoconjunctivitis sicca // Arch. Ophthalmol. – 1979. – Vol. 97. P. 1642–1646.
89. Goldman J., Dohlman C., Kravitt B. The basement membrane of the human cornea in recurrent epithelial erosion syndrome // Trans. Am. Acad. Ophthalmol. Otolaryngol. – 1969. – Vol. 73(3). – P. 471-81.
90. Golubovic S., Parunovic A. Cyanoacrylate glue in the treatment of corneal ulcerations // Fortschr. Ophthalmol. – 1990. – Vol. 87. – P. 378–81.
91. Grinbaum A., Yassur I., Avni I. The beneficial effect of diclofenac sodium in the treatment of filamentary keratitis // Arch. Ophthalmol. – 2001. – Vol. 119. – P. 926-7.
92. Gumus K., Gire A., Pflugfelder S. The successful use of Boston ocular surface prosthesis in the treatment of persistent corneal epithelial defect after herpes zoster ophthalmicus // Cornea. – 2010. – Vol. 29. – P. 1465-8.
93. Gumus K., Lee S., Yen M. et al. Botulinum toxin injection for the management of refractory filamentary keratitis // Arch. Ophthalmol. – 2012. – Vol. 130. – P. 446-50.
94. Guyard M., Perdreil G. Apropos of the treatment of recurrent erosion of the cornea // Bull. Soc. Ophthalmol. Fr. – 1961. – Vol. 6. – P. 579-82.
95. Hamilton W., Wood T. Filamentary keratitis // Am. J. Ophthalmol. – 1982. – Vol. 93. – P. 466-9.
96. Hammar B., Lagali N., Ek S. et. al. Dystrophia Smolandiensis – recurrent corneal erosions with a novel morphological picture // Acta Ophthalmologica. – 2010. – Vol. 88. – P. 394-400.
97. Hammar B., Björck E., Lind H. et al. Dystrophia Helsinglandica: a new type of hereditary corneal recurrent erosions with late subepithelial fibrosis // Acta Ophthalmol. – 2009. – Vol. 87(6). – P. 659-65.
98. Hansen E. Om den intermitterende keratitis visicularis neuralgica Af traumatisk opindelse // Hospitals-Tidende. – 1872. - №51. – P. 201-203.
99. Hao Y., Hui-Kang D., Hwang D. et al. Identification of antiangiogenic and anti-inflammatory proteins in human amniotic membrane // Cornea. – 2000. – Vol. 19. – P. 348–52.
100. Harker D. A modified Schirmer tear test technique. Its uses in aiding the diagnosis of chronic keratoconjunctivitis sicca (filamentary keratitis) in dogs // Vet. Rec. – 1970. – Vol. 14. – P. 196-9.
101. Haschemi H., Taheri S., Fotouchi A., Kheiltash A. Evaluation of prophylactic use of mitomycin C to inhibit haze formation after PTK in high myopia: a prospective clinical study // BMC Ophthalmol. – 2004. – Vol. 1. – P. 12.
102. Hingorani M., Calder V., Buckley R., Lightman S. The immunomodulatory effect of topical cyclosporine A in atopic keratoconjunctivitis // Invest. Ophthalmol. Vis. Sci. – 1999. – № 40. – P. 392-399.
103. Hirsch C. Über die sogenannt "Recidivierende Erosion der Horuihaut" ulnd ihre Behandlung // Prag. Medizen Wochenschr. – 1898. – Vol. 23. – P. 317-320.
104. Hogan B. Laminin and epithelial cell attachment // Nature. – 1981. – Vol. 290. – P. 737-738.
105. Holland E., Olsen T., Ketcham J. et al. Topical cyclosporine A in the treatment of anterior segment inflammatory disease // Cornea. – 1993. – Vol. 12. – P. 413-419.
106. Hope-Ross M. et al. Recurrent corneal erosion: clinical features // Eye (Lond.). – 1994. – Vol. 8. – P. 373-377.
107. Huang W., Chiang C., Tsai Y. Autologous serum eye drops for treating persistent corneal epithelial defect after vitreoretinal surgery // Cornea. – 2008. – Vol. 27. – P. 1097.
108. Huff T., MÜller C., Otto A., Netzker R., et al. Beta-Thymosins, small acidic peptides with multiple functions // Int. J. Biochem. Cell Biol. – 2001. – Vol. 33(3). – P. 205-220.
109. Hull D., Hvndiuk R., Chin G. et al. Clinical experience with the therapeutic hydrophilic contact lens // Ann. Ophthalmol. – 1975. – Vol. 7. – P. 555-562.
110. Jeng B. Treating the nonhealing epithelial defect - an overview of standard and investigational therapies for persistent corneal epithelial defects // Cataract Refractive Surgery Today Europe. – 2011. – Vol. 9 – P. 25–28.
111. Jengand B., Dupps W. Jr. Autologous serum 50% eye drops in the treatment of persistent corneal epithelial defects. – Cornea. – 2009. - Vol. 28. - P. 1104– 1108.
112. Johnson K., Levin F., Chu D. Persistent corneal epithelial defect associated with erlotinib treatment // Cornea. – 2009. – Vol. 28. – P. 706-7.
113. Jones L., MacDougall N., Sorbara L. Asymptomatic corneal staining associated with the use of balafilcon silicone-hydrogel contact lenses disinfected with a polyaminopropyl biguanide-preserved care regimen // Optom. Vis. Sci. – 2002. – Vol. 79. – P. 753-61.
114. Josephson J., Caffery B. Corneal staining after instillation of topical anesthetic (SSII) // Invest. Ophthalmol. Vis. Sci. – 1988. – Vol. 29. – P. 1096-9.
115. Kakizaki H., Zako M., Mito H. et al. Filamentary keratitis improved by blepharoptosis surgery: two cases // Acta Ophthalmol. – 2003. – Vol. 81. – P. 669–671.
116. Kauffmann E. Klinische Studien zur Frage der rezidivierenden erosion // Klin. Monatsbl. Augenheilkd. – 1907. – Vol. 45. – P. 202-210.
117. Kaufman H., Clower J. Irregularities of Bowman's membrane // Am. J. Ophthalmol. 1966. – Vol. 61. – P. 227-230.
118. Khodadoust A., Silverstein A., Kenyon K. et al. Adhesion of regenerating corneal epithelium: the role of basement membrane // Am. J. Ophthalmol. – 1968. – Vol. 57. – P. 311–7.
119. Kim J. et al. The effect of in vivo growth corneal epithelium transplantation on persistent epithelial defects with limbal stem cell deficiency // J. Korean Med. Sci. – 2008. – Vol. 23. – P. 502-508.
120. Kinoshita S., Yokoi N. Filamentary keratitis. In: Foster CS, Azar DT, Dohlman CH, editors. Smolin and Thoft’s the cornea: scientific foundations and clinical practice. 4. Philadelphia: Lippincott Williams & Wilkins. - 2005.
121. Koizumi N., Inatomi T., Sotozono C. et al. Growth factor mRNA and protein in preserved human amniotic membrane // Curr. Eye Res. – 2000. – Vol. 20. – P. 173–7.
122. Kordic R., Suic S., Jandrokovic S. et al. Application of the amniotic membrane extract (AMX) for the persistent epithelial defect (PED) of the cornea // Coll. Antropol. – 2013. – Vol. 37. – P. 161-4.
123. Kowalik B., Rakes J. Filamentary keratitis–the clinical challenges // J. Am. Optom. Assoc. – 1991. – Vol. 62. – P. 200–4.
124. Kruse F., Rohrschneider K., Volcker H. Multilayer amniotic membrane transplantation for reconstruction of deep corneal ulcers // Ophthalmology. – 1999. – Vol. 106. – P. 1504–11.
125. Laibson P., Krachmer J. Familial occurrences of dot (microcystic), map, fingerprint dystrophy of the cornea // Invest. Ophthalmol. – 1975. - №14. – P. 397-399.
126. Langston R., Machamer C., Norman C. Soft lens therapy for recurrent erosion syndrome // Ann. Ophthalmol. – 1978. – Vol. 10. – P. 875-878.
127. Latessa A., Teng C., Katzin H. The hystochemistry of the basement membrane of the cornea // Am. J. Ophthalmol. – 1954. – Vol. 38(2). – P. 171-7.
128. Leber T. Communication to the XIV congress of the German Soc. Ophthalmol. Heidelberg 1882 // Klin. Monatsbl. Augenheilkd. – 1882. – Vol. 20. – P. 165.
129. Ledbetter S., Hassell J., Kleinman H. et al. Induction of heparin sulfate proteoglycan core protein in differentiating cells in culture // J. Cell. Biol. – 1983. – Vol. 97. – P. 458.
130. Lederman M. Radiotherapie de sulcers de la corneen // J. Belge Radiol. – 1951. – Vol. 34. – P. 450-460.
131. Lee S., Li D., Tan D. et al. Suppression of TGF-a signaling in both normal conjunctival fibroblasts and pterygiual body fibroblasts by amniotic membrane // Curr. Eye Res. – 2000. – Vol. 20. – P. 325–34.
132. Lee S., Tseng S. Amniotic membrane transplantation for persistent epithelial defects with ulceration // Am. J. Ophthalmol. – 1997. – Vol. 123. P. 303–12.
133. Leigh A. Therapeutic keratoplasty // Trans. Ophthalmol. Soc. UK. – 1959. – Vol. 79. – P. 439-452.
134. Lekhanont K., Jongkhajornpong P., Choubtum L. et al. Topical 100% serum eye drops for treating corneal epithelial defect after ocular surgery // Biomed. Res. Int. – 2013. Vol. 52. – P. 13-15.
135. Lemp M. Report of the National Eye Institute/Industry workshop on clinical trials in Dry Eyes // CLAO J. – 1995. – Vol. 21. – P. 221–32.
136. Li X., Hu L., Hu J. et al. Investigation of dry eye disease and analysis of the pathogenic factors in patients after cataract surgery // Cornea. – 2007. – Vol. 26. – P. 16–20.
137. Li X., Zhang J., Wang W. Application of lacrimal plug for dry eye patients // Zhonghua Yan Ke Za Zhi. – 2005. – Vol. 41. – P. 1098–1102.
138. Liebman S. An unusual case of filamentary keratitis // AMA Arch. Ophthalmol. – 1955. – Vol. 54. – P. 434-5.
139. Ling J., Gire A., Pflugfelder S. PROSE therapy used to minimize corneal trauma in patients with corneal epithelial defects // Am. J. Ophthalmol. – 2013. – Vol. 155. – P. 615-619.
140. Lopin E., Deveney T., Asbell P. Impression cytology: recent advances and applications in dry eye disease. Review // Ocul. Surf. – 2009. – Vol. 7. – P. 93–110.
141. Lowe R. Recurrent erosion of the cornea // Br. J. Ophthalmol. – 1970. – Vol. 54. – P. 805-9.
142. Lugo M., Arentsen J. Treatment of neurotrophic ulcers with conjunctival flaps // Am. J. Ophthalmol. – 1987. – Vol. 103. – P. 711–2.
143. Lv H., Liu Z., Li X. et al. Effect of lacrimal plugs combined with deproteinized calf blood extract eye gel for filamentary keratitis // J. Ocul. Biol. Dis. Infor. – 2010. – Vol. 3. – P. 134-40.
144. Ma Y., Zhao S., Wang X. et al. A New Recombinant PACAP-Derived Peptide Efficiently Promotes Corneal Wound Repairing and Lacrimal Secretion // Invest. Ophthalmol. Vis. Sci. – 2015. – Vol. 56(8). – P. 4336-49.
145. Macaluso D., Feldman S. Pathogenesis of sterile corneal erosions and ulcerations. In: Krashmer JH, Mannis MJ, Holland EJ, eds. Cornea, fundamentals and cornea and external disease. Missouri: Mosby. - 1997. – P. 204–5.
146. Malinda K., Sidhu G., Mani H. et al. Thymosin beta4 accelerates wound healing // J. Invest. Dermatol. 1999. – Vol. 113(3). – P. 364-368.
147. Maudgal P., Missotten L., Van Deuren H. Study of filamentary keratitis by replica technique // Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. – 1979. – Vol. 2. – P. 11-21.
148. McDonald J., Broekelmann T., Kelley D. et al. Monoclonal antibody to fibronectin's cell adhesive site prevents extracellular matrix formation // J. Cell. Biol. – 1983. – Vol. 97. – P. 3
149. McLean E. et al. Recurrent erosion. Treatment by anterior stromal puncture // Ophthalmology. – 1986. – Vol. 93. – P. 746-8.
150. McNabb H. Recurring erosion of the cornea // Trans. Ophthalmol. Soc. UK. - 1933. Vol. 53. – P. 600-601.
151. Meighan S. Two cases of relapsing traumatic vesicular keratitis // Trans. Ophthalmol. Soc. UK. – 1924. – Vol. 44. – P. 46-56.
152. Menzies J. Detachment of corneal epithelium // Ophthalmol. Rev. - 1902. – Vol. 21. – P. 221-226.
153. Mobilia E., Dohlman C., Holly F. A comparison of various soft contact lenses for therapeutic purposes // Contact Intraoc. Lens. Med. J. – 1977. – Vol. 3. – P. 9-15.
154. Murube J., Nemeth J., Höh H. et al. The triple classification of dry eye for practical clinical use // Eur. J. Ophthalmol. – 2005. – Vol. 15(6). – P. 660-7.
155. Na B., Hwang J., Shin E. et al. Analysis of human amniotic membrane components as proteinas inhibitors for development of therapeutic agent of recalcitrant keratitis // Invest. Ophthalmol. Vis. Sci. – 1998. – Vol. 39. – P. 90.
156. Nakamura T., Inatomi T., Sotozono C. et al. Ocular surface reconstruction using stem cell and tissue engineering // Prog. Retin. Eye Res. – 2016. – Vol. 51. – P. 187-207.
157. Newsome D., Gross J. Prevention by medroxyprogesterone of perforation in the alkali-burned rabbit cornea: inhibition of collagenolytic activity // Invest. Ophthalmol. Vis. Sci. – 1977. – Vol. 16. – P. 21–31.
158. Nichols K., Mitchell G., Simon K. et al. Corneal staining in hydrogel lens wearers // Optom. Vis. Sci. – 2002. – Vol. 79. – P. 20-30.
159. Nishida T., Nakagawa S., Manabe R. Clinical evaluation of fibronectin eyedrops on epithelial disorders after herpetic keratitis // Ophthalmology. – 1985. – Vol. 92. – P. 213–6.
160. Noble B., Loh R., MacLennan S. et al. Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease // British Journal of Ophthalmology. - 2004. - Vol. 88. - P. 647– 652.
161. Obenberger, J. Paper strips and rings as simple tools for standardization of experimental eye injuries / J. Obenberger // Ophthalmol. Res. – 1975. – Vol.7. – P. 363–366.
162. Ormonde S., Chou C., Goold L. et al. Regulation of connexin43 gap junction protein triggers vascular recovery and healing in human ocular persistent epithelial defect wounds // J. Membr. Biol. – 2012. – Vol. 245. – P. 381-8.
163. Oskouee S., Amuzadeh J., Rajabi M. Bandage contact lens and topical indomethacin for treating persistent corneal epithelial defects after vitreoretinal surgery // Cornea. – 2007. – Vol. 26. – P. 1178-81.
164. Ozturk F., Inan U. The effects of acetylcholine and propolis extract on corneal epithelial wound healing in rats // Cornea. – 1999. – Vol. 18. – P. 466–471.
165. Pal-Ghosh S., Pajoohesh-Ganji A., Brown M. et al. A mouse model for the study of recurrent corneal epithelial erosions: alpha9beta1 integrin implicated in progression of the disease // Invest. Ophthalmol. Vis. Sci. – 2004. – Vol. 45. – P. 1775-88.
166. Park W., Tseng S. Temperature cooling reduces keratocyte death in excimer laser ablated corneal and skin wounds // Invest. Ophthalmol. Vis. Sci. – 1998. – Vol. 39. – P. 449.
167. Peters A. Uber Traumatische Hornhauterkrankungen und ihre Beziehungen zum Herpes corneae // Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. – 1904. – Vol. 57. – P. 93-137
168. Pfister R. The normal surface of corneal epithelium: a scanning electron microscopic study // Invest. Ophthalmol. (Copenh). – 1973. – Vol. 12(9). – P. 654–68.
169. Pfister R., Haddox J., Dadson R. et al. Polymorphonuclear leukocytic inhibition by citrate, other metal chelators, and trifluoperazine // Invest. Ophthalmol. Vis. Sci. – 1984. – Vol. 25. – P. 955–70.
170. Prabhasawat P., Barton K., Burkett G. et al. Comparison of conjunctival autografts, amniotic membrane grafts and primary closure for pterygium excision // Ophthalmology. – 1997. – Vol. 104. – P. 974–85.
171. Prabhasawat P., Kosrirukvong P., Booranapong W. et al. Application of preserved human amniotic membrane for corneal surface reconstruction // Cell Tis. Bank. – 2000. – Vol. 1. P. 213–22.
172. Qiu C., Coutinho P., Frank S. et al. Targeting connexin43 expression accelerates the rate of wound repair // Curr. Biol. – 2003. – Vol. 13(19). – P. 1697-1703.
173. Ralph R., Doane M., Dohlman C. Clinical experience with a mobile ocular perfusion pump // Arch. Ophthalmol. – 1975. -Vol. 93(10). - P. 1039–1043.
174. Rea L. Case of filamentary keratitis // Proc. R. Soc. Med. – 1922. – Vol. 15 (Sect. Ophthalmol). – P. 17.
175. Reuss A. Über rezidivierende traumatische Erosionen der Hornhaut // Prag. Medizen Wochenschr. – 1898. – Vol. 21. – P. 243-245.
176. Ricci F., Missiroli F., Ciotti M. et al. Persistent epithelial defect after penetrating keratoplasty caused by adenoviral infectious keratitis // New Microbiol. – 2010. – Vol. 33. – P. 171-4.
177. Ronci C., Ferraro A., Lanti A. et al. Platelet-rich plasma as treatment for persistent ocular epithelial defects // Transfus. Apher. Sci. – 2015. – Vol. 52. – P. 300-4.
178. Rougier M. A propos d'un cas d'erosion recidivante de la cornee // Bull. Soc. Ophthalmol. Fr. – 1953. – Vol. 00. – P. 635-637.
179. Ryan G., Lee G., Maccheron L. Epithelial debridement with diamond burr superficial keratectomy for the treatment of recurrent corneal erosion. // Clin. Experiment Ophthalmol. - 2013. – Vol. 41. – P. 621-2.
180. Sage H. Collagens of basement membranes // J. Invest. Dertmtatol. – 1982. – Vol. 79. – P. 51-59.
181. Santodomingo-Rubido J., Wolffsohn J., Gilmartin B. Changes in ocular physiology, tear film characteristics, and symptomatology with 18 months silicone hydrogel contact lens wear // Optom. Vis. Sci. – 2006. – Vol. 83. – P. 73-81.
182. Sayegh R. et al. Cocaine-assisted epithelial debridement for the treatment of anterior basement membrane dystrophy // Cornea. – 2013. – Vol. 32. – P. 889-92.
183. Schall Klin. Monatsbl. F. Augenh. – 1930. – lxxxv. - P. 406.
184. Schreiber L. Die Behandlung der rezidivierenden Hornhauterosionen mit Scharlachsalbe // Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. – 1914. – Vol. 87. – P. 174-184.
185. Schwallie J., McKenney C., Long B., McNeil A. Corneal staining patterns in normal non-contact lens wearers // Ophthal. Physiol. Opt. – 2001. – Vol. 21. – P. 30-5.
186. Shimazaki J., Hao-Yang Y., Tsubota K. Amniotic membrane transplantation for ocular surface reconstruction in patients with chemical and thermal burns // Ophthalmology. – 1997. – Vol. 104. – P. 2068–76.
187. Shimazaki J., Shinozaki I., Tsubota K. Transplantation of amniotic membrane and limbal autograft for patients with recurrent pterygium associated with symblepharon // Br. J. Ophthalmol. – 1998. – Vol. 82. – P. 235–40.
188. Sjögren H. Zur Kenntnis der Keratoconjunctivitis Sicca (Keratitis filiformis bei Hypofunktion der TränendrÜsen) // Acta Ophthalmol. -1933. - Vol. 2. – P. 1–151.
189. Sonnenberg A., Calafat J., Janssen H. et al. Integrin a6/b4 complex is located in hemidesmosomes, suggesting a major role in epidermal cell-basement membrane adhesion // J. Cell. Biol. – 1991. – Vol. 113. – P. 907–17.
190. Spigelman A., Deutsch T., Sugar J. Application of homologous fibronectin to persistent human corneal epithelial defects // Cornea. – 1987. – Vol. 104. – P. 494– 501.
191. Stanley J., Woodley D., Katz S. et al. Structure and function of basement membrane // J. Invest. Dermatol. – 1982. – Vol. 79. – P. 69-72.
192. Stood W. Über rezidivierende Blasenbildungen auf der Hornhaut des Auges und Keratalgien nach Verletzungen der Hornhautoberflache // Arch. Augenheilkd. – 1901. Vol. 43. – P. 220-228.
193. Su C., Lin C. Combined use of an amniotic membrane and tissue adhesive in treating corneal perforation: a case report // Ophthalmic Surg. Lasers. – 2000. – Vol. 31. – P. 151–4.
194. Sugruie S., Hay E. Response of basal epithelial cell surface and cytoskeleton to solubilized extracellular matrix molecules // J. Cell. Biol. – 1981. – Vol. 91. – P. 45-54
195. Szili A. Über Disjuinction des Hornhaut Epithels // Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. – 1900. - №51. – P. 486-531.
196. Tabery H. Filamentary keratopathy: a non-contact photomicrographic in vivo study in the human cornea // Eur. J. Ophthalmol. – 2003. – Vol. 13. – P. 599–605.
197. Tanioka H., Yokoi N., Komuro A. et al. Investigation of the corneal filament in filamentary keratitis // Invest. Ophthalmol. Vis. Sci. – 2009. – Vol. 50. – P. 3696-702.
198. Teng C. Fine structure of the human cornea: epithelium and stroma // Am. J. Ophthalmol. – 1962. – Vol. 19. – P. 1094-7.
199. Terry R., Schnider C., Holden B. et al. CCLRU standards for success of daily and extended wear contact lenses // Optom. Vis. Sci. – 1993. – Vol. 70. – P. 23-43.
200. Thakrar R. et al. Treatment of recurrent corneal erosions // Eyenet. – 2013. Vol. 1. – P. 39-41.
201. Theodore F. Filamentary keratitis // Contact. Intraocul. Lens Med. J. – 1982. – Vol. 8. – P. 138-46.
202. Theodore F. The use of tension-lowering drugs and other aids in the management of recurrent corneal erosions // Eye Ear Nose Throat Mon. – 1964. – Vol. 43. – P. 62-4.
203. Theophanous C., Parker P., Chiu GB. et al. Use of Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lenses in Patients with Ocular Chronic Graftversus-Host Disease // Biol. Blood Marrow Transplant. – 2015. – Vol. 21(12). – P. 2180-4
204. Thiel HJ, Behnke H. Eine bisher unbekannte subepitheliale hereditäre Hornhautdystrophie. Klin Monatsbl Augenheilkd. – 1967. – Vol. 150. – P. 862–874.
205. Thoft R., Mobilia E. Complications with therapeutic extended wear soft contact lenses // Int. Ophthalmol. Clin. – 1981. – Vol. 21. – P. 197-208.
206. Thygeson P. Observations on recurrent erosion of the cornea // Am. J. Ophthalmol. – 1959. – Vol. 47(5). – P. 155-70.
207. Timpl R., Engel J., Martin G. Laminin - A multifunctional protein of basement membranes // Tr. Biochem. Sci. – 1983. – Vol. 8. – P. 207-209.
208. Timpl R., Rohde H. Laminin – A glycoprotein from basement membranes // J. Cell. Biol. – 1979. – Vol. 254. – P. 9933-9937.
209. Tripathi R., Bron A. Ultrastructural study of non-traumatic recurrent corneal erosion // Br. J. Ophthalmol. – 1972. – Vol. 56. – P. 73-85.
210. Trobe J., Laibson P. Dystrophic changes in the anterior cornea // Arch. Ophthalmol. – 1972. – Vol. 87(4). – P. 378-82.
211. Tseng S., Li D., Ma X. Suppression of transforming growth factor beta isoforms, TGF-a receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix // J. Cell. Physiol. – 1999. – Vol. 179. – P. 325–35.
212. Tseng S., Prabhasawat P., Barton K. et al. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency // Arch. Ophthalmol. – 1998. - Vol. 116. P. 431–41.
213. Tseng S., Prabhasawat P., Lee S. Amniotic membrane transplantation for conjunctival surface reconstruction // Arch. Ophthalmol. – 1997. – Vol. 124. – P. 765– 74.
214. Tseng S., Tsubota K. Important concepts for treating ocular surface and tear disorders // Am. J. Ophthalmol. – 1997. – Vol. 124. – P. 825–35.
215. Tsubota K., Goto E., Fujita H. et al. Treatment of dry eye by autologous serum application in Sjogren’s syndrome // British Journal of Ophthalmology. – 1999. -Vol. 83. - P. 390–395.
216. Tsubota K., Goto E., Shimmura S. et al. Treatment of persistent corneal epithelial defect by autologous serum application // Ophthalmology. – 1999. - Vol. 106. - P. 1984–1989.
217. Tsubota K., Satake Y., Ohyama M. et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome // Am. J. Ophthalmol. – 1996. – Vol. 122. – P. 38–52.
218. Ubels J., McCartney M., Lantz W. et al. Effects of preservative-free artificial tear solutions on corneal epithelial structure and function // Arch. Ophthalmol. – 1995. – Vol. 113. – P. 371–378.
219. Valle O. Heridetary recurring corneal erosions a familial study with special reference to Fuchs’ dystrophy // Acta Ophthalmol. – 1967. – Vol. 45. – P. 829-836.
220. Verhoeff F. Neuropathic keratitis and some allied conditions with special reference to treatment // J. Am. MedAssoc. – 1909. – Vol. 53. – P. 191-198.
221. Vogt A. Lehrbuch und Atlas der Spaltlampenmikroskopie des lebenden Auges, 2 ed. Springer, Berlin. - 1930. – Vol. 1. – P. 246.
222. Wagenmanin X. Über rezidivierende erosionen der Kornea // MÜnchen Medizen Wochenschr. – 1904. – Vol. 2. – P. 93-95.
223. Wales H. A family history of corneal erosion // Trans. Ophthalmol. Soc. NZ. – 1955. - №8. – P. 77-78.
224. Weiss J., Moller H., Aldave A. et al. IC3D classification of corneal dystrophies – edition 2 // Cornea. – 2015. – Vol. 34. – P. 117-59.
225. Welch C., Baum J. Tarsorrhaphy for corneal disease in patients with rheumatoid arthritis // Ophthalmic Surg. – 1988. – Vol. 19. – P. 31–2.
226. Weskamp C. Parenchymatous origin of filamentary keratitis; new histopathologic concepts // Am. J. Ophthalmol. – 1956. – Vol. 42. – P. 115-20.
227. Whitcher J., Shiboski C., Shiboski S. et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from Sjögren’s syndrome international registry // Am. J. Ophthalmol. – 2010. – Vol. 149(3). – P. 405-415.
228. Williams R., Buckley R. Pathogenesis and treatment of recurrent erosion // Br. J. Ophthalmol. – 1985. – Vol. 69(6). – P.435-7.
229. Willis R., Folberg R., Krachmer J., Holland E. The treatment of aqueousdeficient dry eye with removable punctal plugs. A clinical and impression-cytologic study // Ophthalmology. – 1987. – Vol. 94(5). – P. 514-8.
230. Wirostko B., Rafii M., Sullivan D. et al. Novel Therapy to Treat Corneal Epithelial Defects: A Hypothesis with Growth Hormone // Ocul. Surf. – 2015. – Vol. 13. – P. 204-212.
231. Wolffsohn J. Incremental nature of anterior eye grading scales determined by objective image analysis // Br. J. Ophthalmol. – 2004. – Vol. 88. – P. 1434-8.
232. Wood T. Reccurrent erosion // Tr. Am. Ophth. Soc. – 1984. – Vol. LXXXII. – P. 850-898.
233. Wright P. Filamentary keratitis // Trans. Ophthalmol. Soc. UK. – 1975. – Vol. 95. – P. 260-6.
234. Wu W., Zeng L., Peng Y. et al. The effects of recombinant human epithelialgrowth factor and protein-free calf blood extract for recovery of corneal mechanical epithelial defects healing and neovascularization // Eur. Rev. Med. Pharmacol. Sci. – 2014. – Vol. 18. – P. 3406-11.
235. Yee R., Sullivan L., Lai H. et al. Linkage mapping of Thiel-Behnke corneal dystrophy (CDB2) to chromosome 10q23-q24 // Genomics. – 1997. – Vol. 46. – P. 152– 154.
236. Yoon K. Use of umbilical cord serum in ophthalmology // Chonnam. Med. J. - 2014. - Vol. 50. – P. 82-5.
237. Yow H.,Walker E., Song J. et al. Characterization and effects of highly purified fibronectin matrices // J. Cell. Biol. (Abstr.). – 1983. – Vol. 97. – P. 325.
238. Zaidman G., Geeraets R., Paylor R. e al. The histopathology of filamentary keratitis //Arch. Ophthalmol. – 1985. – Vol. 103. – P. 1178-81.
239. Ziakas N. et al. Long-term follow up of autologous serum treatment for recurrent corneal erosions // Clin. Experiment. Ophthalmol. – 2010. – Vol. 38. – P. 683-7.
Страница источника: 97-119
OAI-PMH ID: oai:eyepress.ru:article24471
Просмотров: 10708
Каталог
Продукции
Организации
Офтальмологические клиники, производители и поставщики оборудования
Издания
Периодические издания
Партнеры
Проекта Российская Офтальмология Онлайн